Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Multi-modal Assessment of GABA Function in Psychosis

NCT04004416 is registered in ClinicalTrials.gov with University of Michigan as lead sponsor.

NCT NCT04004416
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04004416 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Multi-modal Assessment of GABA Function in Psychosis
Lead sponsor
University of Michigan
Phase
Phase 4
Overall status
Completed
Start date
January 16, 2020
Completion date
February 28, 2025
Enrollment
143 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

bipolar disorder, healthy, major depression with psychotic features, psychosis, schizo affective disorder, schizophrenia, schizophreniform disorders